Therefore, the aim of the study is to investigate the CNV of PI3K subunits and their relationship with clinicopathological features exploring the possible mechanism underlying of PI3K activation in DLBCL. The gene discussed is PIK3CD; the disease is diffuse large B-cell lymphoma.